Media & Entertainment Growth Investors & VC Firms
452 firms in this list, with a median first check of $1M. 113 of them lead rounds. Generated from verified public data and updated continuously.
Export and Investment Fund
CopenhagenSeed–Growth$108K – $7.6M
13 people
Kalon Venture Partners
JohannesburgSeed–Growth
13 people
Sycamore Ventures
PrincetonGrowth–Late Stage$5M – $20M
13 people
Bregal Milestone
LondonGrowth$33M – $165M
9 people
Conconi Growth Partners
VancouverSeries A–Growth$36.5K – $2.2M
9 people
Hundreds Capital
BeijingGrowth
3 people
Spire Capital Partners Sp. z.o.o.
WarszawaGrowth–Late Stage$5M – $20M
11 people
Vantage Capital
JohannesburgGrowth
8 people
Smile Group
SingaporeSeed–Late Stage
13 people
Cue Ball
BostonSeed–Growth$100K – $10M
9 people
Draycott
LisbonSeed–Late Stage
4 people
NEVEQ Capital Partners Ltd.
SofiaSeed–Growth$324K – $3.2M
3 people
Detong Capital
ShanghaiSeed–Growth$20M
11 people
Ventura Capital
LondonGrowth–Late Stage
5 people
Kenya Development Corporation
NairobiGrowth
16 people
Tiny Capital
VictoriaGrowth
3 people
Dot Capital
New YorkSeed–Late Stage$750K – $4M
5 people
Orange Digital Ventures
Issy-les-MoulineauxSeed–Growth
13 people
Progress Ventures
BostonSeed–Growth
6 people
Capital Mills
GorinchemGrowth$270K – $2.7M
5 people
Chrysalis Ventures
LouisvilleSeries A–Growth$1M – $10M
4 people
Gibraltar Ventures
TorontoSeed–Growth
10 people
Tappan Hill Ventures
Ann ArborSeed–Late Stage$100K
5 people
Mitsukoshi Isetan Innovations
TokyoSeed–Growth$3M
12 people
Related lists
Growth Investors & VC Firms (4282)Growth Investors & VC Firms in North America (2128)Growth Investors & VC Firms in United States (1845)Growth Investors & VC Firms in Europe (1638)Media & Entertainment Investors & VC Firms (1435)Growth Investors & VC Firms in Global (1384)Healthtech Growth Investors & VC Firms (1277)Growth Investors & VC Firms in Asia-Pacific (1258)Enterprise Software Growth Investors & VC Firms (1202)SaaS Growth Investors & VC Firms (1185)
Data sourced from public filings and firms' own websites — see our methodology.
























































































